NRx Pharmaceuticals, Inc.
NRXP
$3.37
-$0.10-2.88%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.69M | 6.71M | 7.80M | 7.18M | 2.91M |
| Total Receivables | 206.00K | 181.00K | 161.00K | 3.33M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.19M | 240.00K | 590.00K | 1.44M | 919.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.08M | 227.00K | 344.00K | -- | 761.00K |
| Total Current Assets | 29.16M | 7.36M | 8.89M | 11.95M | 4.59M |
|
|
|||||
| Total Current Assets | 29.16M | 7.36M | 8.89M | 11.95M | 4.59M |
| Net Property, Plant & Equipment | 1.75M | 1.20M | 696.00K | 419.00K | 8.00K |
| Long-term Investments | 1.79M | 1.79M | 1.79M | 610.00K | -- |
| Goodwill | 1.79M | 1.79M | 1.79M | 610.00K | -- |
| Total Other Intangibles | 832.00K | 879.00K | 925.00K | 1.78M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 224.00K | 276.00K | 253.00K | 243.00K | 240.00K |
| Total Assets | 34.16M | 11.90M | 12.96M | 15.00M | 4.84M |
|
|
|||||
| Total Accounts Payable | 3.15M | 4.40M | 4.27M | 4.26M | 3.63M |
| Total Accrued Expenses | 6.02M | 5.42M | 5.62M | 5.47M | 5.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 378.00K | 391.00K | 316.00K | 10.10M | 9.85M |
| Total Finance Division Other Current Liabilities | 24.33M | 14.96M | 18.37M | 20.77M | 20.98M |
| Total Other Current Liabilities | 24.33M | 14.96M | 18.37M | 20.77M | 20.98M |
| Total Current Liabilities | 33.87M | 25.18M | 28.58M | 40.59M | 40.45M |
|
|
|||||
| Total Current Liabilities | 33.87M | 25.18M | 28.58M | 40.59M | 40.45M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 456.00K | 543.00K | 315.00K | 158.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 34.33M | 25.72M | 28.89M | 40.75M | 40.45M |
|
|
|||||
| Common Stock & APIC | 324.68M | 294.51M | 290.96M | 281.50M | 265.75M |
| Retained Earnings | -324.85M | -308.33M | -306.90M | -307.26M | -301.37M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -170.00K | -13.82M | -15.94M | -25.76M | -35.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -170.00K | -13.82M | -15.94M | -25.76M | -35.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -170.00K | -13.82M | -15.94M | -25.76M | -35.62M |
|
|
|||||